Book Appointment Now
About Genoxus Labs
Turning Genetic Complexity Into Clinical Clarity
Genoxus Labs exists to make sense of genetic data—so clinicians, researchers, and healthcare organizations can make better, faster, and more confident decisions. As genomic data grows exponentially, insight has not kept pace. At Genoxus Labs, we bridge that gap by transforming raw genetic files into clear, actionable intelligence using rigorous science, advanced data processing, and a platform built for real-world clinical impact.
Our Mission
Our mission is to unlock the full potential of genomic data through precise, secure, and clinically meaningful analysis. We believe genetic information should empower decision-making, not overwhelm it—delivering insights that are accurate, interpretable, and ready for real-world clinical and research use.
Our Vision
We envision a future where genomic insights are seamlessly embedded into everyday healthcare and research—enabling personalized treatment, accelerating discovery, and improving outcomes worldwide. Genoxus Labs is building the scientific and technical foundation to help make that future a reality.
Our Approach
Our approach is science-first and clinician-minded. We integrate biological validation, trusted external data sources, and scalable technology to translate complex genetic data into clear, actionable insights—designed for accuracy, transparency, and meaningful real-world impact.
Our Team
Jingqi Duan, CEO and Founder of Genoxus, is a biotech-focused leader working at the intersection of structural biology, genomics, and AI/ML. He holds a PhD in Biotechnology from Peking University and has over a decade of experience spanning academic research, software development, and machine learning–driven genomics. Jingqi has led advanced research at institutions including HHMI and the University of Pennsylvania, and most recently built clinical annotation and AI platforms for next-generation sequencing data. Based in San Diego, he combines deep wet-lab expertise with scalable software engineering to turn complex genomic data into actionable insight—driven by both scientific rigor and personal motivation as a parent of a neurodiverse child. More on Jingqi Duan.
段景琦 是 Genoxus 的创始人兼首席执行官，是一位专注于生物技术领域的领导者，致力于结构生物学、基因组学以及人工智能/机器学习（AI/ML）的交叉研究与应用。他拥有北京大学生物技术博士学位，并在学术研究、软件开发以及机器学习驱动的基因组学领域拥有超过十年的经验。JD 曾在多个知名研究机构开展前沿研究工作，包括 HHMI 和宾夕法尼亚大学，并且最近构建了用于下一代测序（NGS）数据的临床注释和人工智能平台。
点击这里了解更多关于 段景琦 的信息
点击这里了解更多关于 段景琦 的信息
What are the primary pain-points Genoxus is working on? (3:19 min)
Who stands to gain the most from a partnership with Genoxus? (47 sec)
What drives your personal commitment to the work Genoxus is doing? (54 sec)
Clarity Starts With the Right Platform
Genoxus helps turn genomic complexity into meaningful insight—so you can focus on discovery, diagnosis, and impact.
What Genoxus DoesOne Platform. Clear Answers.
Genoxus is a genetic data processing and interpretation platform built to support clinical research, translational science, and precision medicine. We ingest standard VCF files and systematically analyze genetic variants across multiple variant types, connecting each finding to curated scientific and clinical evidence to generate clear, interpretable insights.
Why GenoxusGenomic Insight Without the Noise
Most genomic tools overwhelm users with raw data or opaque scores. Genoxus is different. Our platform delivers transparent variant interpretation, structured outputs designed for scientific and clinical use, and scalable analysis from single samples to large datasets. The result is decision-ready insight you can trust—not just more data.
Who It’s ForFor Data & Discovery Teams
Genoxus is designed for researchers, clinicians, bioinformatics teams, and life science organizations working in precision medicine. If your work depends on understanding genetic variation and translating it into action, Genoxus helps you move faster with confidence and clarity.
Join Us on the Journey
We collaborate with clinicians, researchers, healthcare organizations, and strategic partners who share our commitment to advancing precision medicine.